SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Citurgia Biochemicals submits revised unaudited financial results

29 Dec 2023 Evaluate

Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, Citurgia Biochemicals has informed that it enclosed revised Standalone unaudited Financial Results for the quarter ended on 30th June, 2023. Further, it has informed that in earlier submission dated 21st October, 2023, Limited Review Report issued by the statutory auditor for the quarter ended on 30th June, 2023 could not be submitted. Except above, there is no change in the results submitted to stock exchange dated 21st October, 2023. 

The above information is a part of company’s filings submitted to BSE.


Citurgia Biochem Share Price

95.55 -1.90 (-1.95%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3693.20
Tata Chemicals 707.70
SRF 2474.05
Pidilite Inds. 1407.65
Deepak Nitrite 1645.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×